A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

Ankit Aggarwal is an Executive Director at J.P. Morgan in New York, where he leads capital markets and strategic advisory for ...

CapsoVision, Inc.'s IPO exhibits high risks with slowing revenue growth, rising losses, and excessive valuation. Learn why a ...

Blue Water Logistics Limited, a multimodal transport operator is set to be listed on NSE Emerge platform on June 03, 2025. The company’s IPO recorded 9.36 times subscription until the final day of ...

Morgan Stanley On Dr Agarwal’s Healthcare Maintained 'overweight' rating with a target price of Rs 502. The quarter ended March was good overall. Earnings before interest, taxes, depreciation and ...

The counters of Ajax Engineering, Dr Agarwal's Health Care, Ather Energy, and Hexaware Technologies will be among the major ...

The General Insurance Council (GIC) of India, the apex industry body representing all non-life insurers in India, on Wednesday launched a nationwide awareness campaign titled ‘Achha Kiya Insurance ...

A marginally strong average seen this year is largely due to the strong HNI interest seen in IPOs launched in January ...

The IPO market is buzzing with new offerings this year, but there’s a twist — High Net Worth Individuals (HNIs) are clearly ...

Shenu Agarwal, MD and CEO of Ashok Leyland, said while it may take another two to three years to achieve its mid-teen margin target, the company is firmly on track, with steady year-on-year progress.

HDFC Securities' CEO suggests Nifty valuations are reasonable given strong growth expectations, despite earlier forecast ...

These delays add to the growing list of Indian firms putting their IPO plans on hold, including JSW Cement, South Korean conglomerate LG Electronics' India unit.